| Bioactivity | Pegnivacogin sodium is a novel RNA-aptamer based factor IXa inhibitor featuring a reversal agent, anivamersen. |
| Name | Pegnivacogin sodium |
| Formula | C327H391F11N114Na31O213P31 (C2H4O)n |
| Molar Mass | 51.2 kDa (Approximately) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Staudacher DL, Putz V, Heger L, et al. Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2019;8(6):520-526. doi:10.1177/2048872617703065 |
Pegnivacogin sodium
CAS: F: C327H391F11N114Na31O213P31 (C2H4O)n W: 51.2 kDa (Approximately)
Pegnivacogin sodium is a novel RNA-aptamer based factor IXa inhibitor featuring a reversal agent, anivamersen.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.